Calfactant Sterility in Multiple Doses from Single-Use Vials
BACKGROUND: Calfactant is an exogenous surfactant used to treat and prevent respiratory distress syndrome in the newborn infant. It is available in single-use preservative-free vials, but contains enough volume to provide multiple doses to small infants. OBJECTIVE: To measure the preservation of cal...
Gespeichert in:
Veröffentlicht in: | The Annals of pharmacotherapy 2003-09, Vol.37 (9), p.1219-1223 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1223 |
---|---|
container_issue | 9 |
container_start_page | 1219 |
container_title | The Annals of pharmacotherapy |
container_volume | 37 |
creator | Reiter, Pamela D Sims, Cheri Harmes, Lisa Paisley, Jan Rosenberg, Adam A Valuck, Robert J |
description | BACKGROUND:
Calfactant is an exogenous surfactant used to treat and prevent respiratory distress syndrome in the newborn infant. It is available in single-use preservative-free vials, but contains enough volume to provide multiple doses to small infants.
OBJECTIVE:
To measure the preservation of calfactant sterility at 12- and 24-hour intervals following initial violation of vial contents and to extrapolate cost savings associated with product conservation.
METHODS:
A prospective sterility study was performed using calfactant suspension obtained from vials prescribed for infants who had received their dose in the delivery room or the neonatal intensive care unit (NICU). After initial vial entry, test vials were stored in the NICU pharmacy satellite under refrigeration (temperature range 2.2–7.2 °C). Re-entry of test vials and sample removal was performed 12 and 24 hours after initial entry with an 18- or 20-gauge needle. All samples were removed by a neonatal respiratory therapist and placed into 3-mL latex-free, Leurlok plastic syringes and examined by 3 culture media: MacConkey agar, blood agar, and thioglycollate broth.
RESULTS:
A total of 89 surfactant samples from 45 vials were cultured; 45 at a mean time of 13.36 hours (range 11–41) and 44 at a mean time of 25.8 hours (range 22–60) after initial vial entry. These samples represented the technique of multiple respiratory therapists. All samples were negative for bacterial growth at 24 and 48 hours (β = 0.9).
CONCLUSIONS:
Results from this short-term sterility study represent an initial step in the evaluation of multiple doses of surfactant from a single-use vial. The data suggest that 1–2 re-entries into a vial of calfactant, within 24 hours after the initial breach, can be a safe and economical method of providing more than a single dose of surfactant to infants weighing |
doi_str_mv | 10.1345/aph.1C463 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73587584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1345_aph.1C463</sage_id><sourcerecordid>73587584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-d606d1ed0e0031c363bd0c7c5f21a7e63a7f9511b3adea726e2251072b93c0033</originalsourceid><addsrcrecordid>eNptkD1PwzAQhi0EglIY-AMoC0gMgbNdx43EgsqnBGIoZbVc59IaOUmxE1X99xgaqQvL3Q3P3Xt6CDmjcE35SNzo1fKaTkYZ3yMDKkYszZiE_ThDBimwMRyR4xC-ACCnLD8kR7EyKoANyO1Eu1KbVtdtMm3RW2fbTWLr5K1zrV05TO6bgCEpfVMlU1svHKazgMmn1S6ckIMyNjzt-5DMHh8-Js_p6_vTy-TuNTVc8jYtMsgKigUgAKeGZ3xegJFGlIxqiRnXsswFpXOuC9SSZciYoCDZPOcmrvAhudzeXfnmu8PQqsoGg87pGpsuKMnFWIrxKIJXW9D4JgSPpVp5W2m_URTUryoVVak_VZE974928wqLHdm7icBFD-hgoiWva2PDjhMwZkKw3XdBL1B9NZ2vo4x_E3twaRfLtfWoQqWdi_lUrddrLlUe02nOfwBs7IkF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73587584</pqid></control><display><type>article</type><title>Calfactant Sterility in Multiple Doses from Single-Use Vials</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Reiter, Pamela D ; Sims, Cheri ; Harmes, Lisa ; Paisley, Jan ; Rosenberg, Adam A ; Valuck, Robert J</creator><creatorcontrib>Reiter, Pamela D ; Sims, Cheri ; Harmes, Lisa ; Paisley, Jan ; Rosenberg, Adam A ; Valuck, Robert J</creatorcontrib><description>BACKGROUND:
Calfactant is an exogenous surfactant used to treat and prevent respiratory distress syndrome in the newborn infant. It is available in single-use preservative-free vials, but contains enough volume to provide multiple doses to small infants.
OBJECTIVE:
To measure the preservation of calfactant sterility at 12- and 24-hour intervals following initial violation of vial contents and to extrapolate cost savings associated with product conservation.
METHODS:
A prospective sterility study was performed using calfactant suspension obtained from vials prescribed for infants who had received their dose in the delivery room or the neonatal intensive care unit (NICU). After initial vial entry, test vials were stored in the NICU pharmacy satellite under refrigeration (temperature range 2.2–7.2 °C). Re-entry of test vials and sample removal was performed 12 and 24 hours after initial entry with an 18- or 20-gauge needle. All samples were removed by a neonatal respiratory therapist and placed into 3-mL latex-free, Leurlok plastic syringes and examined by 3 culture media: MacConkey agar, blood agar, and thioglycollate broth.
RESULTS:
A total of 89 surfactant samples from 45 vials were cultured; 45 at a mean time of 13.36 hours (range 11–41) and 44 at a mean time of 25.8 hours (range 22–60) after initial vial entry. These samples represented the technique of multiple respiratory therapists. All samples were negative for bacterial growth at 24 and 48 hours (β = 0.9).
CONCLUSIONS:
Results from this short-term sterility study represent an initial step in the evaluation of multiple doses of surfactant from a single-use vial. The data suggest that 1–2 re-entries into a vial of calfactant, within 24 hours after the initial breach, can be a safe and economical method of providing more than a single dose of surfactant to infants weighing <1 kg. We encourage each institution to reproduce these findings before applying this concept to their patients.</description><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1C463</identifier><identifier>PMID: 12921502</identifier><identifier>CODEN: APHRER</identifier><language>eng</language><publisher>Los Angeles, CA: Harvey Whitney Books</publisher><subject>Bacteria - isolation & purification ; Biological and medical sciences ; Biological Products ; Drug Contamination ; Drug Packaging ; Drug Storage ; Humans ; Infant ; Infant, Newborn ; Infant, Premature ; Intensive Care Units ; Medical sciences ; Pharmacology. Drug treatments ; Pulmonary Surfactants - administration & dosage ; Pulmonary Surfactants - analysis ; Pulmonary Surfactants - economics ; Respiratory Distress Syndrome, Newborn - drug therapy ; Respiratory system ; Retrospective Studies ; Time Factors</subject><ispartof>The Annals of pharmacotherapy, 2003-09, Vol.37 (9), p.1219-1223</ispartof><rights>2003 SAGE Publications</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-d606d1ed0e0031c363bd0c7c5f21a7e63a7f9511b3adea726e2251072b93c0033</citedby><cites>FETCH-LOGICAL-c373t-d606d1ed0e0031c363bd0c7c5f21a7e63a7f9511b3adea726e2251072b93c0033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1345/aph.1C463$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1345/aph.1C463$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15082552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12921502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reiter, Pamela D</creatorcontrib><creatorcontrib>Sims, Cheri</creatorcontrib><creatorcontrib>Harmes, Lisa</creatorcontrib><creatorcontrib>Paisley, Jan</creatorcontrib><creatorcontrib>Rosenberg, Adam A</creatorcontrib><creatorcontrib>Valuck, Robert J</creatorcontrib><title>Calfactant Sterility in Multiple Doses from Single-Use Vials</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><description>BACKGROUND:
Calfactant is an exogenous surfactant used to treat and prevent respiratory distress syndrome in the newborn infant. It is available in single-use preservative-free vials, but contains enough volume to provide multiple doses to small infants.
OBJECTIVE:
To measure the preservation of calfactant sterility at 12- and 24-hour intervals following initial violation of vial contents and to extrapolate cost savings associated with product conservation.
METHODS:
A prospective sterility study was performed using calfactant suspension obtained from vials prescribed for infants who had received their dose in the delivery room or the neonatal intensive care unit (NICU). After initial vial entry, test vials were stored in the NICU pharmacy satellite under refrigeration (temperature range 2.2–7.2 °C). Re-entry of test vials and sample removal was performed 12 and 24 hours after initial entry with an 18- or 20-gauge needle. All samples were removed by a neonatal respiratory therapist and placed into 3-mL latex-free, Leurlok plastic syringes and examined by 3 culture media: MacConkey agar, blood agar, and thioglycollate broth.
RESULTS:
A total of 89 surfactant samples from 45 vials were cultured; 45 at a mean time of 13.36 hours (range 11–41) and 44 at a mean time of 25.8 hours (range 22–60) after initial vial entry. These samples represented the technique of multiple respiratory therapists. All samples were negative for bacterial growth at 24 and 48 hours (β = 0.9).
CONCLUSIONS:
Results from this short-term sterility study represent an initial step in the evaluation of multiple doses of surfactant from a single-use vial. The data suggest that 1–2 re-entries into a vial of calfactant, within 24 hours after the initial breach, can be a safe and economical method of providing more than a single dose of surfactant to infants weighing <1 kg. We encourage each institution to reproduce these findings before applying this concept to their patients.</description><subject>Bacteria - isolation & purification</subject><subject>Biological and medical sciences</subject><subject>Biological Products</subject><subject>Drug Contamination</subject><subject>Drug Packaging</subject><subject>Drug Storage</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Intensive Care Units</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Surfactants - administration & dosage</subject><subject>Pulmonary Surfactants - analysis</subject><subject>Pulmonary Surfactants - economics</subject><subject>Respiratory Distress Syndrome, Newborn - drug therapy</subject><subject>Respiratory system</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkD1PwzAQhi0EglIY-AMoC0gMgbNdx43EgsqnBGIoZbVc59IaOUmxE1X99xgaqQvL3Q3P3Xt6CDmjcE35SNzo1fKaTkYZ3yMDKkYszZiE_ThDBimwMRyR4xC-ACCnLD8kR7EyKoANyO1Eu1KbVtdtMm3RW2fbTWLr5K1zrV05TO6bgCEpfVMlU1svHKazgMmn1S6ckIMyNjzt-5DMHh8-Js_p6_vTy-TuNTVc8jYtMsgKigUgAKeGZ3xegJFGlIxqiRnXsswFpXOuC9SSZciYoCDZPOcmrvAhudzeXfnmu8PQqsoGg87pGpsuKMnFWIrxKIJXW9D4JgSPpVp5W2m_URTUryoVVak_VZE974928wqLHdm7icBFD-hgoiWva2PDjhMwZkKw3XdBL1B9NZ2vo4x_E3twaRfLtfWoQqWdi_lUrddrLlUe02nOfwBs7IkF</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Reiter, Pamela D</creator><creator>Sims, Cheri</creator><creator>Harmes, Lisa</creator><creator>Paisley, Jan</creator><creator>Rosenberg, Adam A</creator><creator>Valuck, Robert J</creator><general>Harvey Whitney Books</general><general>SAGE Publications</general><general>Whitney</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030901</creationdate><title>Calfactant Sterility in Multiple Doses from Single-Use Vials</title><author>Reiter, Pamela D ; Sims, Cheri ; Harmes, Lisa ; Paisley, Jan ; Rosenberg, Adam A ; Valuck, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-d606d1ed0e0031c363bd0c7c5f21a7e63a7f9511b3adea726e2251072b93c0033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Bacteria - isolation & purification</topic><topic>Biological and medical sciences</topic><topic>Biological Products</topic><topic>Drug Contamination</topic><topic>Drug Packaging</topic><topic>Drug Storage</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Intensive Care Units</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Surfactants - administration & dosage</topic><topic>Pulmonary Surfactants - analysis</topic><topic>Pulmonary Surfactants - economics</topic><topic>Respiratory Distress Syndrome, Newborn - drug therapy</topic><topic>Respiratory system</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reiter, Pamela D</creatorcontrib><creatorcontrib>Sims, Cheri</creatorcontrib><creatorcontrib>Harmes, Lisa</creatorcontrib><creatorcontrib>Paisley, Jan</creatorcontrib><creatorcontrib>Rosenberg, Adam A</creatorcontrib><creatorcontrib>Valuck, Robert J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reiter, Pamela D</au><au>Sims, Cheri</au><au>Harmes, Lisa</au><au>Paisley, Jan</au><au>Rosenberg, Adam A</au><au>Valuck, Robert J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calfactant Sterility in Multiple Doses from Single-Use Vials</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>37</volume><issue>9</issue><spage>1219</spage><epage>1223</epage><pages>1219-1223</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><coden>APHRER</coden><abstract>BACKGROUND:
Calfactant is an exogenous surfactant used to treat and prevent respiratory distress syndrome in the newborn infant. It is available in single-use preservative-free vials, but contains enough volume to provide multiple doses to small infants.
OBJECTIVE:
To measure the preservation of calfactant sterility at 12- and 24-hour intervals following initial violation of vial contents and to extrapolate cost savings associated with product conservation.
METHODS:
A prospective sterility study was performed using calfactant suspension obtained from vials prescribed for infants who had received their dose in the delivery room or the neonatal intensive care unit (NICU). After initial vial entry, test vials were stored in the NICU pharmacy satellite under refrigeration (temperature range 2.2–7.2 °C). Re-entry of test vials and sample removal was performed 12 and 24 hours after initial entry with an 18- or 20-gauge needle. All samples were removed by a neonatal respiratory therapist and placed into 3-mL latex-free, Leurlok plastic syringes and examined by 3 culture media: MacConkey agar, blood agar, and thioglycollate broth.
RESULTS:
A total of 89 surfactant samples from 45 vials were cultured; 45 at a mean time of 13.36 hours (range 11–41) and 44 at a mean time of 25.8 hours (range 22–60) after initial vial entry. These samples represented the technique of multiple respiratory therapists. All samples were negative for bacterial growth at 24 and 48 hours (β = 0.9).
CONCLUSIONS:
Results from this short-term sterility study represent an initial step in the evaluation of multiple doses of surfactant from a single-use vial. The data suggest that 1–2 re-entries into a vial of calfactant, within 24 hours after the initial breach, can be a safe and economical method of providing more than a single dose of surfactant to infants weighing <1 kg. We encourage each institution to reproduce these findings before applying this concept to their patients.</abstract><cop>Los Angeles, CA</cop><pub>Harvey Whitney Books</pub><pmid>12921502</pmid><doi>10.1345/aph.1C463</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1060-0280 |
ispartof | The Annals of pharmacotherapy, 2003-09, Vol.37 (9), p.1219-1223 |
issn | 1060-0280 1542-6270 |
language | eng |
recordid | cdi_proquest_miscellaneous_73587584 |
source | Access via SAGE; MEDLINE |
subjects | Bacteria - isolation & purification Biological and medical sciences Biological Products Drug Contamination Drug Packaging Drug Storage Humans Infant Infant, Newborn Infant, Premature Intensive Care Units Medical sciences Pharmacology. Drug treatments Pulmonary Surfactants - administration & dosage Pulmonary Surfactants - analysis Pulmonary Surfactants - economics Respiratory Distress Syndrome, Newborn - drug therapy Respiratory system Retrospective Studies Time Factors |
title | Calfactant Sterility in Multiple Doses from Single-Use Vials |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T18%3A18%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calfactant%20Sterility%20in%20Multiple%20Doses%20from%20Single-Use%20Vials&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Reiter,%20Pamela%20D&rft.date=2003-09-01&rft.volume=37&rft.issue=9&rft.spage=1219&rft.epage=1223&rft.pages=1219-1223&rft.issn=1060-0280&rft.eissn=1542-6270&rft.coden=APHRER&rft_id=info:doi/10.1345/aph.1C463&rft_dat=%3Cproquest_cross%3E73587584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73587584&rft_id=info:pmid/12921502&rft_sage_id=10.1345_aph.1C463&rfr_iscdi=true |